David Hung
President and CEO, Director, 10% owner at Nuvation Bio Inc. (NUVB) since February 2021
David Hung has filed 18 insider reports with the SEC since February 2021, as director at NovoCure Ltd (NVCR) and president and CEO, director and 10% owner at Nuvation Bio Inc. (NUVB). In the last 12 months David Hung sold $46.4K of stock on the open market. The latest filing, on June 5, 2026, reports grant or award at NovoCure Ltd (NVCR).
- Filings
- 18
- Companies
- 2
- Bought on market
- $1.71M
- Sold on market
- $63.7K
Companies where David Hung is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 32,075 | $63.7K | $10.71 | Jun 5, 2026 | |||
| President and CEO, Director, 10% ownersince February 2021 | 59,281,054 | $1.71M | $1.71 | $3.80+122% | Mar 4, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 3, 2026NVCRDirector Hung David was granted 11,610 units of Ordinary Shares, increasing direct ownership by 57% to 32,075 unitsForm 4Grant or award
- Jun 2, 2026-$46.4KNVCRDirector Hung David sold $46,445 worth of Ordinary Shares (2,945 units at $15.77), decreasing direct ownership by 13% to 20,465 units (for withholding tax)Form 4Open-market sale
- Feb 27, 2026NUVBSEC Form 4 filed by PRESIDENT AND CEO Hung DavidForm 4Grant or award
- Jun 16, 2025+$894KNUVBPRESIDENT AND CEO Hung David bought $893,500 worth of shares (500,000 units at $1.79), increasing direct ownership by 0.85% to 59,281,054 unitsForm 4Open-market purchase
- Jun 4, 2025NVCRDirector Hung David was granted 11,215 units of Ordinary Shares, increasing direct ownership by 92% to 23,410 unitsForm 4Grant or award
- Jun 3, 2025-$17.3KNVCRDirector Hung David sold $17,280 worth of Ordinary Shares (999 units at $17.30), decreasing direct ownership by 8% to 12,195 unitsForm 4Open-market sale
- Apr 7, 2025+$820KNUVBPRESIDENT AND CEO Hung David bought $820,220 worth of shares (500,000 units at $1.64), increasing direct ownership by 0.86% to 58,781,054 unitsForm 4Open-market purchase
- Feb 28, 2025NUVBSEC Form 4 filed by PRESIDENT AND CEO Hung DavidForm 4Grant or award
- Jun 5, 2024NVCRHung David was granted 4,053 units of Restricted Stock Units, increasing direct ownership by 44% to 13,194 unitsForm 4Grant or award
- Feb 29, 2024NUVBSEC Form 4 filed by Hung DavidForm 4Grant or award
- Jun 7, 2023NVCRSEC Form 4 filed by Hung DavidForm 4Grant or award
- Feb 28, 2023NUVBSEC Form 4: Hung David disposed of 368,408 shares, decreasing direct ownership by 0.63% to 58,281,054 unitsForm 4Grant or awardOther acquisition or disposition
- Jun 8, 2022NVCRSEC Form 4: Hung David was granted 2,427 units of Restricted Stock Units, increasing direct ownership by 36% to 9,141 unitsForm 4Grant or award
- Feb 28, 2022NUVBSEC Form 4 filed by Hung DavidForm 4Grant or award
- Jun 9, 2021NVCRSEC Form 4: Hung David was granted 814 units of Restricted Stock Units, increasing direct ownership by 14% to 6,714 unitsForm 4Grant or award
- Mar 9, 2021NUVBSEC Form 4 filed by David HungForm 4Grant or award
- Feb 10, 2021NUVBSEC Form 4: David Hung was granted 58,645,012 units of Class A Common StockForm 4Grant or award
- Feb 10, 2021NUVBSEC Form 3: David Hung claimed no ownership of No securities owned.Form 3New insider
Also sits on boards with
Officers and directors who share two or more companies with David Hung.
Compare David Hung with
- David Hung vs W Anthony Vernon2 shared
- David Hung vs Mukund Paravasthu1 shared
- David Hung vs Christoph Brackmann1 shared
- David Hung vs Michal Nath Puri1 shared
- David Hung vs Gary Hattersley1 shared
- David Hung vs Philippe Sauvage1 shared
Other insiders at the same companies
- Mukund ParavasthuNVCR
- Christoph BrackmannNVCR
- Michal Nath PuriNVCR
- Gary HattersleyNUVB
- Philippe SauvageNUVB
- Frank X LeonardNVCR
- Arye Barak BenNVCR
- Asaf DanzigerNVCR
- Stacy MarkelNUVB
- Kerry WentworthNUVB
- Robert MashalNUVB
- Gabriel LeungNVCR
- Kristin StaffordNVCR
- Allyson J OceanNVCR
- Timothy J ScannellNVCR
- Jeryl L HillemanNVCR
Questions about David Hung
- What is David Hung's role at Nuvation Bio Inc.?
- David Hung reports to the SEC as president and CEO, director and 10% owner at Nuvation Bio Inc. (NUVB), according to the latest filing on March 4, 2026. David Hung has also filed as director at NovoCure Ltd (NVCR).
- How many shares does David Hung own?
- After the latest filing that states it, David Hung directly owned 32,075 shares of NovoCure Ltd (NVCR) and 59,281,054 shares of Nuvation Bio Inc. (NUVB). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has David Hung bought or sold stock recently?
- The most recent open-market purchase was on June 16, 2025: bought 500,000 shares of Nuvation Bio Inc. (NUVB) for $894K at an average of $1.79. The most recent open-market sale was on June 2, 2026: sold 2,945 shares of NovoCure Ltd (NVCR) for $46.4K at an average of $15.77.
- How do I get alerts when David Hung files?
- Follow David Hung on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by David Hung (SEC CIK 0001310880). Totals count each trade once, skipping amendments whose original is on file, from Feb 12, 2021 on. View on SEC EDGAR · Get this as JSON